For the quarter ending 2025-09-30, AHCO had $11,727K increase in cash & cash equivalents over the period. $66,824K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 25,750 | 9,749 |
| Depreciation and amortization, including patient equipment depreciation | 97,716 | 186,705 |
| Goodwill impairment | 0 | 0 |
| Equity-based compensation | 5,311 | 11,427 |
| Change in fair value of warrant liability | 0 | 0 |
| Reduction in the carrying amount of operating lease right-of-use assets | 7,646 | 15,300 |
| Reduction in the carrying amount of finance lease right-of-use assets | 3,846 | 7,096 |
| Deferred income tax expenses | 34,524 | 12,643 |
| Change in fair value of interest rate swaps, net of reclassification adjustment | 0 | 0 |
| Amortization of deferred financing costs | 1,332 | 3,105 |
| Loss on extinguishment of debt | 0 | - |
| Payment of contingent consideration from an acquisition | 0 | 0 |
| Gain on sale of businesses | 0 | 32,225 |
| Other | 3,000 | - |
| Accounts receivable | -13,274 | -8,868 |
| Inventory | 36 | 9,713 |
| Prepaid and other assets | 70,481 | 4,578 |
| Operating lease obligations | -7,662 | -15,812 |
| Operating liabilities | 46,846 | 64,956 |
| Net cash provided by operating activities | 161,066 | 257,521 |
| Purchases of equipment and other fixed assets | 94,242 | 184,250 |
| Payments for business acquisitions, net of cash acquired | 0 | 18,561 |
| Proceeds from the sale of businesses, net of cash disposed | 1,501 | 115,674 |
| Proceeds from the sale of assets | 0 | - |
| Receipt of contingent consideration from the sale of assets | 0 | 1,156 |
| Net cash used in investing activities | -92,741 | -85,981 |
| Repayments on long-term debt and lines of credit | 50,000 | 175,000 |
| Proceeds from borrowings on lines of credit | 0 | 0 |
| Repayments of finance lease obligations | 3,833 | 8,346 |
| Proceeds from the exercise of stock options | 0 | 0 |
| Proceeds received in connection with employee stock purchase plan | 646 | 564 |
| Payments relating to the tax receivable agreement | 33 | 25,012 |
| Payments of debt financing costs | 0 | - |
| Distributions to noncontrolling interests | 2,853 | 2,573 |
| Payments for tax withholdings from vesting of restricted stock units | 525 | 2,079 |
| Payments of contingent consideration and deferred purchase price from acquisitions | 0 | 211 |
| Net cash used in financing activities | -56,598 | -212,657 |
| Net (decrease) increase in cash | 11,727 | -41,117 |
| Cash and cash equivalents at beginning of period | 109,747 | - |
| Cash and cash equivalents at end of period | 80,357 | - |
AdaptHealth Corp. (AHCO)
AdaptHealth Corp. (AHCO)